Regístrese
Buscar en
Revista Española de Reumatología
Toda la web
Inicio Revista Española de Reumatología Tratamiento del paciente con dispepsia asociada al consumo de AINE
Información de la revista
Vol. 27. Núm. 1.
Páginas 36-38 (Enero 2000)
Compartir
Compartir
Más opciones de artículo
Vol. 27. Núm. 1.
Páginas 36-38 (Enero 2000)
Acceso a texto completo
Tratamiento del paciente con dispepsia asociada al consumo de AINE
Treatment of nonsteroidal antiinflammatory drugs associated dyspepsia
Visitas
1499
Josep M Piquéa
a Servicio de Gastroenterolog??a. Institut de Malalties Digestives. Hospital Cl??nic. Universidad de Barcelona.
Información del artículo
Bibliografía
Estadísticas
Bibliografía
[1]
Saunders JH, Oliver RJ, Higson DL..
Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice..
Br Med J, 292 (1986), pp. 665-8
[2]
Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF..
Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study..
Arch Intern Med, 156 (1996), pp. 1530-6
[3]
Singh G, Triadafilopoulos G..
Epidemiology of NSAID induced gastrointestinal complications..
J Rheumathol, 26(Supl56) (1999), pp. 18-24
[4]
Sadowski DC..
Drug interactions with antiacids. Mechanisms and clinical significance..
Drug Saf, 1 (1994), pp. 395-407
[5]
Van Groenendael JH, Markuse HM, Dijkmans BA, Breedveld FC..
The effect of ranitidine on NSAID related dyspeptis symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis..
Clin Rheumatol, 15 (1996), pp. 450-6
[6]
French PC, Darekar BS, Mills JG, Wood JR..
Ranitidine in the prevention of non-steroidal anti-inflammatory drug-associated gastric and duodenal ulceration in arthritic patients..
Eur J Gastroenterol Hepatol, 6 (1994), pp. 1141-7
[7]
Taha AS, Hudson N, Hawley CJ, Swannell AJ, Trye PN, Cottrell J et al..
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs..
N Engl J Med, 334 (1996), pp. 1435-9
[8]
Graham DY, Agrawal NW, Roth SH..
Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial..
Lancet, 2 (1988), pp. 1277-80
[9]
Graham DY, White RH, Moreland LW, Schubert TT, Katz R, Jaszewski R et al..
Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSIDs..
Ann Intern Med, 119 (1993), pp. 257-62
[10]
Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB et al..
Misoprostol dosage in the prevention of nonsteroidal antiinflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens..
Ann Intern Med, 123 (1995), pp. 344-50
[11]
Elliot SL, Yeomans ND, Buchanan RR.C, Smallwood RA..
Efficacy of 12 months. Misoprostol as prophylaxis agaisnt NSAID-induced gastric ulcers..
Scand J Rheumatol, 23 (1994), pp. 171-6
[12]
Agrawal NM, Roth S, Graham DY, White RH, Germain B, Brown JA et al..
Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer: a randomized, controlled trial..
Ann Intern Med, 115 (1991), pp. 195-200
[13]
Rodríguez de la Serna A, Díaz Rubio M, and Spanish Study Group on NSAID-induced Gastropathy Prevention..
Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenterology..
J Rheumatol, 21 (1994), pp. 927-33
[14]
Yeomans MD, Tulassay ZT, Juhasz L, Racz I, Howard JM, Van Rensburg CJ et al..
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflamatory drugs..
N Engl J Med, 338 (1998), pp. 719-26
[15]
Hawkey CJ, Karrasch JA, Szcepanski L, Walker DG, Barkun A, Swannell AJ et al..
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs..
N Engl J Med, 338 (1998), pp. 727-34
[16]
Hawkey CJ, Tulassay Z, Szczepanski L, Van Rensburg CJ, Filipowicz-Sosnowka A, Lanas A et al..
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter eradication for lesion prevention..
Lancet, 352 (1998), pp. 1016-21
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.